20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
As the fall-out from COVID-19 threatens to sink entire portfolios, PE sponsors and CEO’s need to walk a tightrope between preserving organisational capabilities in order to resume growth in case of a rebound in 2H 2020, while at the same time preparing to survive a protracted recession or even depression if things go wrong.
Our latest HumaticaCorner explores the options for portfolio managers and CEOs.
The Economics of AI Disruption The story of AI is not about tools — it’s about economics. AI collapses interface costs, compresses overhead, and enables…
Read more
Firsthand strategies from portfolio company CEO’s who outperformed in uncertain times Portfolio company leaders are facing bigger challenges than ever before. Unprecedented macro-headwinds from increased…
Read more
With interest rates at levels not seen in over a decade, the private equity model has entered a new phase—one where operational excellence is no…
Read more
Erhalten Sie jeden Monat Neuigkeiten und wertvolle Perspektiven zu Themen der organisatorischen Effektivität
